Literature DB >> 11120654

Melatonin secretion occurs at a constant rate in both young and older men and women.

J B Fourtillan1, A M Brisson, M Fourtillan, I Ingrand, J P Decourt, J Girault.   

Abstract

The magnitude and duration of melatonin (MLT) secretion were measured over a period of 25 h with pharmacokinetic studies employing administration of D(7) MLT at midday and at midnight in two separate studies and two groups of subjects, 12 young and 11 older men and women. Plasma levels of endogenous MLT and D(7) MLT were quantified separately by use of a specific and sensitive method (gas chromatography-mass spectrometry) previously developed in our laboratory, enabling us to measure endogenous and exogenous MLT levels down to 0.5 pg/ml in plasma. In the two groups of subjects, MLT secretion occurred only at night: onset time of secretion was from 1915 to 2205 (Greenwich mean time), and offset was from 0305 to 0545. No MLT peak was observed in individual nocturnal MLT profiles that were similar to curves obtained for a rate-constant infusion. Modelization demonstrated the superimposition of observed data and simulated curves. MLT concentrations decreasing from the offset of secretion might correspond to the elimination of MLT present in the body at the end of nocturnal secretion. By use of the MLT clearance given by pharmacokinetics, the amount of secreted MLT was found to be 35.7 and 21.6 microg for men and women, respectively, and the rate of secretion was 4.6 and 2.8 microg/h, respectively. No significant gender difference was observed for these two parameters when normalized to body weight. No significant gender difference was observed for onset times of secretion or duration of secretion (7.6-8.6 h) within the two groups, or between young and older subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120654     DOI: 10.1152/ajpendo.2001.280.1.E11

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

Review 2.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

3.  Pharmacokinetics of melatonin in preterm infants.

Authors:  Nazakat M Merchant; Denis V Azzopardi; Ahmed F Hawwa; James C McElnay; Benita Middleton; J Arendt; Tomoki Arichi; Pierre Gressens; A David Edwards
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 4.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  Premedication with melatonin vs midazolam: efficacy on anxiety and compliance in paediatric surgical patients.

Authors:  Pietro Impellizzeri; Enrica Vinci; Maria Cristina Gugliandolo; Francesca Cuzzocrea; Rosalba Larcan; Tiziana Russo; Maria Rosaria Gravina; Salvatore Arena; Gabriella D'Angelo; Eloisa Gitto; Angela Simona Montalto; Angela Alibrandi; Lucia Marseglia; Carmelo Romeo
Journal:  Eur J Pediatr       Date:  2017-05-24       Impact factor: 3.183

6.  Use of transdermal melatonin delivery to improve sleep maintenance during daytime.

Authors:  D Aeschbach; B J Lockyer; D-J Dijk; S W Lockley; E S Nuwayser; L D Nichols; C A Czeisler
Journal:  Clin Pharmacol Ther       Date:  2009-07-15       Impact factor: 6.875

7.  Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study.

Authors:  Ingvild Saksvik-Lehouillier; Stephanie L Harrison; Lynn M Marshall; Greg J Tranah; Kristine Ensrud; Sonia Ancoli-Israel; Aaron Clemons; Susan Redline; Katie L Stone; Eva S Schernhammer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-11       Impact factor: 6.053

8.  Role of melatonin in the induction and maintenance of sleep.

Authors:  Jean B Fourtillan
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

9.  Melatonin, immune function and aging.

Authors:  V Srinivasan; G J M Maestroni; D P Cardinali; A I Esquifino; S R Pandi Perumal; S C Miller
Journal:  Immun Ageing       Date:  2005-11-29       Impact factor: 6.400

Review 10.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.